Skip to main content
. 2018 Sep 4;13:1565–1577. doi: 10.2147/CIA.S160756

Table 1.

Participants with complete dose of iPACES™ vs inadequate dose

Timepoint Variable Complete dose
(≤2×/wk)
Inadequate dose
(≤2×/wk)
p-value
Ave SD Ave SD
Demographics Age 69.40 13.81 61.60 13.05 0.31
Education (years) 15.80 2.39 14.80 2.28 0.45
MoCA 24.70 3.56 23.20 4.97 0.51
Pretrial Color Trails ratio 1/2 0.45 0.16 0.45 0.03 1.00
Digit Span ratio F/B 0.65 0.17 0.69 0.21 0.70
Stroop ratio A/C 0.49 0.10 0.38 0.16 0.11
Word recall (ADAS delayed) 6.83 1.17 6.00 3.54 0.60
Midtrial (6 weeks) Color Trails ratio 1/2 0.50 0.14 0.41 0.05 0.20
Digit Span ratio F/B 0.71 0.24 0.67 0.18 0.84
Stroop ratio A/C 0.49 0.11 0.43 0.24 0.50
Word recall (ADAS delayed) 8.00 2.76 6.40 3.78 0.44
Posttrial (3 months) Color Trails ratio 1/2 0.44 0.11 0.36 0.11 0.19
Digit Span ratio F/B 0.62 0.09 0.53 0.24 0.34
Stroop ratio A/C 0.53 0.12 0.41 0.14 0.10
Word recall (ADAS delayed) 8.83 0.98 6.20 3.90 0.14

Abbreviations: iPACES, interactive Physical and Cognitive Exercise System; MoCA, Montreal Cognitive Assessment; ADAS, Alzheimer’s Disease Assessment Scale; Ave, average; wk, week.